Roche appoints Mark Dawson as new Head of Pharma Research and Early Development
Dawson joins Roche from the Peter MacCallum Cancer Centre, where he serves as Associate Director of Research
Dawson joins Roche from the Peter MacCallum Cancer Centre, where he serves as Associate Director of Research
UK Prime Minister Keir Starmer praised the initiative, saying: “Unlocking opportunities for British businesses across the globe and delivering for working people back home is always the driving force behind my international engagements."
Steve joins Sai Life Sciences from GlaxoSmithKline (GSK) where he was a department head and member of the global chemical development leadership team.
The decision follows authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) in May 2022.
First launches expected in H1 2022
State-of-the-art R&D facility designed to foster collaboration across world-class science ecosystem
Subscribe To Our Newsletter & Stay Updated